Status:
UNKNOWN
Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)
Lead Sponsor:
Mashhad University of Medical Sciences
Conditions:
Alzheimer Disease
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Alzheimer's disease (AD) is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability to function independently. Despite the significant...
Detailed Description
Purpose of the study: A randomized, triple-blind, pilot clinical trial has been designed to evaluate the effectiveness of trehalose on reducing the symptoms in AD patients. Study intervention: twenty ...
Eligibility Criteria
Inclusion
- Mini-Mental State Examination (MMSE) score range from 10 to 23
- Not having other cognitive disorders
Exclusion
- MMSE score higher than 23 or lower than 10
- The presence of other cognitive disorders which will be evaluated by clinical assessment and brain imaging
- The presence of factors affecting cognitive impairment such as depression
- Vascular dementia and Lewy body dementia
- Previous history of head trauma
- Use of alcohol and other drugs that affect cognitive functioning
Key Trial Info
Start Date :
August 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04663854
Start Date
August 20 2020
End Date
August 20 2022
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghaem Educational, Research and Treatment Center
Mashhad, Razavi Khorasan Province, Iran, 9919991766